Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
0.6431
-0.0269 (-4.01%)
Mar 31, 2025, 1:27 PM EDT - Market open
Biodesix Employees
Biodesix had 273 employees as of December 31, 2024. The number of employees increased by 56 or 25.81% compared to the previous year.
Employees
273
Change (1Y)
56
Growth (1Y)
25.81%
Revenue / Employee
$261,256
Profits / Employee
-$157,256
Market Cap
93.88M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 273 | 56 | 25.81% |
Dec 31, 2023 | 217 | -28 | -11.43% |
Dec 31, 2022 | 245 | 27 | 12.39% |
Dec 31, 2021 | 218 | 18 | 9.00% |
Dec 31, 2020 | 200 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
BDSX News
- 27 days ago - Biodesix, Inc. (BDSX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 27 days ago - Biodesix Announces Fourth Quarter and Fiscal Year 2024 Results - GlobeNewsWire
- 4 weeks ago - Biodesix to Present at TD Cowen 45th Annual Health Care Conference - GlobeNewsWire
- 5 weeks ago - Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 - GlobeNewsWire
- 2 months ago - Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited) - GlobeNewsWire
- 2 months ago - Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study - GlobeNewsWire
- 5 months ago - Biodesix, Inc. (BDSX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Biodesix Announces Third Quarter 2024 Results and Highlights - GlobeNewsWire